19th April 2009

The genetic X-factor

Nine new X chromosome genes associated with learning disabilities

CASK

Family with missense variants in the CASK gene, one of the genes discovered in this study. Individuals with the missense variant are denoted by a *. Females are denoted with circles and males with squares. Black shading denotes individuals with learning disabilities.

A collaboration between more than 70 researchers across the globe has uncovered nine new genes on the X chromosome that, when knocked-out, lead to learning disabilities. The international team studied almost all X chromosome genes in 208 families with learning disabilities - the largest screen of this type ever reported.

Remarkably, the team also found that approximately 1-2% of X chromosome genes, when knocked-out, have no apparent effect on an individual's ability to function in the ordinary world. The publication - a culmination of five years of scientific collaboration - emphasises the power of sequencing approaches to identify novel genes of clinical importance, but also highlights the challenges researchers face when carrying out this kind of study.

Estimates suggest that the prevalence of learning disability is 2-3%. Learning disability is significantly more common in males than in females and genetic causes have long been sought on the X chromosome: males have only one X chromosome and so a gene mutation on the X is more likely to have an effect in males than in females.

"We sequenced 720 out of the approximately 800 known genes on the X chromosome in more than 200 families affected by X-linked learning disabilities," explains Professor Mike Stratton, from the Wellcome Trust Sanger Institute. "This is the largest sequencing study of complex disease ever reported."

In part because of their apparent effects in males, X-linked disorders have been well studied by geneticists over the past 25 years. Conceived by Dr Lucy Raymond, from the University of Cambridge, and Professor Mike Stratton, the collaborative study harnessed DNA sequencing to detect as many new abnormal genes as possible. In the future similar strategy will be used to find disease causing sequence variants implicated in other complex genetic diseases.

" We sequenced 720 out of the approximately 800 known genes on the X chromosome in more than 200 families affected by X-linked learning disabilities. This is the largest sequencing study of complex disease ever reported. "

Prof Mike Stratton

Some characteristics in common could be identified in patients with variants in the same gene. However, in many, learning disability was the only feature. The newly identified genes play roles in a wide range of biological processes suggesting that disruption to many cellular machines can damage the nervous system.

"As well as these important new gene discoveries relating to learning disability, we have also uncovered a small proportion - 1% or more - of X chromosome protein-coding genes that, when knocked out, appear to have no effect on the characteristics of the individual," explains Mike Stratton. "It is remarkable that so many protein-coding genes can be lost without any apparent effect on an individual's normal existence - this is a surprising result and further research will be necessary in this area."

This finding will also act as a warning to geneticists. Large-scale studies are designed to uncover associations between knocked-out genes and disease. However, this study shows that a small proportion of gene knock-outs have no discernable effect on the individual. In future studies, researchers must therefore be cautious about assuming that the presence of a knocked out gene in an individual with a particular disease means that the knocked out gene is causing the disease.

The research comes towards the end of a long process of gene cataloguing in this field. Scientists believe that there are likely to be more undiscovered genes that contribute to X-linked learning disabilities; however, variants at what are expected to be lower frequency will become increasingly difficult and costly to uncover. The next challenge is to implement this improved knowledge of the complex of genes that lead to learning disabilities in clinical practice.

"We already offer genetic counselling to families with X-linked learning disabilities," says Dr Lucy Raymond, Reader in Neurogenetics, Cambridge Institute for Medical Research at the University of Cambridge. "This new research uncovers yet more genes that can be incorporated to improve the provision of diagnostics to families with learning disabilities and allow us to develop more comprehensive genetic counselling in the future, allowing parents and the extended family to make the most informed family planning decisions."

Although in most cases improved treatments remain to be developed, information about a genetic condition can provide support to affected families. The information can also help to inform reproductive choices.

Notes to Editors

Publication details

Tarpey PS et al. (2009) A systematic, large-scale resequencing screen of the X chromosome coding exons in mental retardation. Nature Genetics. Published online before print as doi: 10.1038/ng.367

Funding

This research was supported by the New South Wales Department of Health, the Australian National Health and Medical Research Council, the SMILE foundation, the WCH Foundation, Adelaide, Mr D Harwood, the European Union, the US National Institutes of Health, the South Carolina Department of Disabilities and Special Needs (SCDDSN), Action Medical Research and the Wellcome Trust.

Participating Centres

  • Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK
  • Molecular Genetics Laboratory, Hospital de Cruces, 48903 Barakaldo, Bizkaia, Spain
  • Unidad de Genética y Diagnóstico Prenatal, Hospital Universitario La Fe, Av/Campanar, Valencia, Spain
  • MRC Human Genetics Research Unit, Faculty of Health Sciences, University of Cape Town, South Africa
  • Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  • Center for Human Genetics, University Hospital Leuven, Leuven, Belgium
  • INSERM 129-ICGM, Faculté de Médecine Cochin, Paris, France
  • INSERM, U930; Centre Hospitalier Régional Universitaire de Tours, Service de Génétique, Tours, France
  • Department of Human Molecular Genetics, Max Planck Institute for Molecular Genetics, Berlin-Dahlem, Germany
  • Cambridge Institute of Medical Research, Cambridge, UK
  • Guy's Hospital, Great Maze Pond, London, UK
  • Institute of Medical Genetics, Yorkhill Hospital, Glasgow, UK
  • SA Pathology, Women's and Children's Hospital, North Adelaide, SA, Australia
  • Cancer Research UK Genetic Epidemiology Unit, Strangeways Research Laboratory, Cambridge, UK
  • GOLD Service, Hunter Genetics, Waratah, NSW, Australia
  • JC Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, SC, USA
  • The University of Adelaide, Adelaide, SA, Australia
  • Institute of Cancer Research, Surrey, UK

University of Cambridge

As the University of Cambridge celebrates its eight-hundredth anniversary in 2009, it is looking to the future. Its mission is to contribute to society through the pursuit of education, learning and research at the highest international levels of excellence. It admits the very best and brightest students, regardless of background, and offers one of the UK's most generous bursary schemes.

The University of Cambridge's reputation for excellence is known internationally and reflects the scholastic achievements of its academics and students, as well as the world-class original research carried out by its staff. Some of the most significant scientific breakthroughs occurred at the University, including the splitting of the atom, invention of the jet engine and the discoveries of stem cells, plate tectonics, pulsars and the structure of DNA. From Isaac Newton to Stephen Hawking, the University has nurtured some of history's greatest minds and has produced more Nobel Prize winners than any other UK institution with over 80 laureates.




The Wellcome Trust Sanger Institute

The Wellcome Trust Sanger Institute, which receives the majority of its funding from the Wellcome Trust, was founded in 1992. The Institute is responsible for the completion of the sequence of approximately one-third of the human genome as well as genomes of model organisms and more than 90 pathogen genomes. In October 2006, new funding was awarded by the Wellcome Trust to exploit the wealth of genome data now available to answer important questions about health and disease.

Websites

The Wellcome Trust

The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests.

Website

Sanger Institute Contact Information:

Don Powell Press Officer
Wellcome Trust Sanger Institute Hinxton, Cambs, CB10 1SA, UK

Tel +44 (0)1223 496 928
Mobile +44 (0)7753 7753 97
Fax +44 (0)1223 494 919
Email press.office@sanger.ac.uk

* quick link - http://q.sanger.ac.uk/ki41dcv3